Title	Response evaluation
Number of patients screened	85
Number of patients enrolled	70
Number of patients evaluable for toxicity	70
Number of patients evaluated for efficacy	70
Evaluation Method	RECIST 1.1
Response assessment, CR	1 (1.4%)
Response assessment, PR	21 (30%)
Response assessment, SD	23 (32.9%)
Response assessment, PD or death	24 (34.3%)
Outcome notes	Table 2 shows a summary of AEs. Table 3 shows response by treatment group. Table 4 shows pharmacokinetic parameters. Table 5 shows response by tumor histology.